NMR spectroscopic studies on the late onset form of 3-methylglutaconic aciduria type I and other defects in leucine metabolism

Udo F.H. Engelke, Berry Kremer, Leo A.J. Kluijtmans, Marinette van der Graaf, Eva Morava, Ference J. Loupatty, Ronald J.A. Wanders, Detlef Moskau, Sandra Loss, Erik van den Bergh, Ron A. Wevers

Research output: Contribution to journalReview article

34 Scopus citations

Abstract

A diagnosis of 3-methylglutaconic aciduria type I (OMIM: 250950) based on elevated urinary excretion of 3-methylglutaconic acid (3MGA), 3-methylglutaric acid (3MG) and 3-hydroxyisovaleric acid (SHIVA) was made in a 61-year-old female patient presenting with leukoencephalopathy slowly progressing over more than 30 years. The diagnosis was confirmed at the enzymatic and molecular level. In vivo brain MR spectroscopic imaging (MRSI) was performed at 3.0 T, and one-dimensional and two-dimensional in vitro NMR spectroscopy of body fluids of the patient was performed at 11.7 T. Additionally, we measured 1D 1H-NMR spectra of urine of seven patients with a total of four different inborn errors of leucine metabolism. Increased concentrations of 3HIVA, 3MGA (cis and trans) and 3MG were observed in the NMR spectra of the patient's urine. In the cerebrospinal fluid, the 3HIVA concentration was 10 times higher than in the plasma of the patient and only the cis isomer of 3MGA was observed. In vivo brain MRSI showed an abnormal resonance at 1.28 ppm that may be caused by 3HIVA. Comparison of 1H-NMR spectra of urine samples from all eight patients studied, representing five different inborn errors of leucine metabolism, showed that each disease has typical NMR characteristics. Our leukoencephalopathy patient suffers from a late-onset form of 3-methylglutaconic aciduria type I. In the literature, only very few adult patients with this conditions have been described, and 3HIVA accumulation in white matter in the brain has not been presented before in these patients. Our data demonstrate that 1H-NMR spectroscopy of urine can easily discriminate between the known inborn errors of leucine metabolism and provide the correct diagnosis.

Original languageEnglish (US)
Pages (from-to)271-278
Number of pages8
JournalNMR in Biomedicine
Volume19
Issue number2
DOIs
StatePublished - Apr 2006

Keywords

  • 3-hydroxyisovaleric acid
  • 3-methylglutaconic aciduria type I
  • Geometric isomerism of 3-methylglutaconic acid
  • Leucine brain metabolism
  • Leukoencephalopathy
  • NMR spectroscopy

ASJC Scopus subject areas

  • Molecular Medicine
  • Radiology Nuclear Medicine and imaging
  • Spectroscopy

Fingerprint Dive into the research topics of 'NMR spectroscopic studies on the late onset form of 3-methylglutaconic aciduria type I and other defects in leucine metabolism'. Together they form a unique fingerprint.

  • Cite this

    Engelke, U. F. H., Kremer, B., Kluijtmans, L. A. J., van der Graaf, M., Morava, E., Loupatty, F. J., Wanders, R. J. A., Moskau, D., Loss, S., van den Bergh, E., & Wevers, R. A. (2006). NMR spectroscopic studies on the late onset form of 3-methylglutaconic aciduria type I and other defects in leucine metabolism. NMR in Biomedicine, 19(2), 271-278. https://doi.org/10.1002/nbm.1018